|
Thursday, 7 February 2019 (Grand Hyatt Doha Hotel)
|
|
Morning Workshop from 9am to 12 pm (3 CPD)
|
|
Workshop Title
|
Presenter
|
|
Psychiatric Emergencies
Recognize clinical presentations and underlying causes for psychiatric emergencies
- Identify treatment goals in addressing psychiatric emergencies
- Implement evidence-based practices when managing various psychiatric emergencies
- Design a monitoring plan for various psychiatric emergencies
|
Dr. Tawny Smith, PharmD, FASHP, BCPP
|
|
Geriatric prescribing
- Review historical Development of international Assessment tool
- List Factors affecting selection and development of Assessment tool in Qatar
- Explain Medications involved in in-appropriate prescribing
- Apply 4- How to promote safe older adults medicine prescribing practice
|
Dr. Ameena Al Yazeedi, BSc(Pharm), MBA, BCGP, CPHQ
Dr. Ahmed Fouad, BSc(Pharm), BCPS, BCGP
|
|
Change and Time Management
- Analyze, plan, implement and follow up change process
- Recognize and prioritize the opportunities and identify key stakeholders to start and sustain the important changes
- Conduct the conversation with the stakeholders important for change implementation
- Engage different groups of participants in the change management and recognize the most important players in the process
- Build a strong strategy to guide your team to lead the change management
- Recognize the barriers and facilitators to manage the desired change
- Motivate your colleagues to start change process with a strong vision and dedication
- Understand two different types of priority
- Decide what is urgent and what is important
|
Dr. sc Arijana Meštrović, MPharm, FFIP
Dr. Michael Rouse, B.Pharm (Hons); MPS; FFIP
|
|
Establishing Interprofessional Education and Practice Experiences
- Identify key concepts related to interprofessional education and practice (IPE/P)
- Describe effective models for promoting IPE/P in a didactic and clinical practice setting
- Design an initial outline of an interprofessional clinical experience for your students
|
Dr. Zachary (Zach) Weber, PharmD, BCPS, BCACP, CDE
|
|
Optimizing success in research funding applications
- State the key elements of a research funding application
- Outline the main criteria by which applications will be judged
- Construct research aims, objectives, questions and hypotheses
- Develop a research impact and dissemination plan
|
Professor Derek Stewart, PgCert, BSc, MSc, PhD, FRPharmS, FFRPS
|
|
Afternoon Workshops from 1pm to 4 pm (3 CPD)
|
|
Workshop Title
|
Presenter
|
|
Pharmacotherapy of ECMO: Focus on Drug Disposition and Pharmacokinetics
- Describe the potential alterations that extracorporeal membrane oxygenation (ECMO) can have on medications.
- Recommend serum concentration monitoring strategies for pharmacotherapy in patients undergoing ECMO
- Recommend dosing strategies for medications commonly used in pediatric patients undergoing ECMO
|
Dr. Brady Moffett, PharmD, MPH
|
|
A Primer to the Emerging Role of Pharmacists in Anti-Doping in Sport
- Recognize the international regulations regarding doping in sport
- Review the criteria for inclusion of substances/methods in the WADA Prohibited List.
- Identify the drugs listed under WADA Prohibited List according to their category
- Explain the reasons for misuse, pharmacological actions, and adverse health consequences of selected prohibited substances/methods.
- Explain the meaning and the application process of Therapeutic Use Exemption (TUE).
- Recognize the role of Qatar Anti-doping Commission (QADC), with emphasis on Testing and Investigation
- Discuss the role of pharmacists and other ASP in fighting against doping in sport and ensuring safe, effective, and legal use of drugs in sport.
|
Dr. Fatima Al Malki, PhD
Dr. Ahmed Awaisu, PhD, B.Pharm
Dr. Afif Ahmed, B. Pharm, MSc
|
|
Introduction, Overview and Management" - Seizing the Day with Modern Anti-Seizure Drugs
- Discuss the rationale for using combination antiseizure drugs over monotherapy
- Compare and contrast the side effect profile of the traditional antiseizure drugs vs. the newer anti-seizure drugs
- Describe the considerations for changes in drug therapy given a patient with focal onset seizures
- Discuss the need for individualized antiseizure drug treatment in a given patient
|
Dr. Jacquelyn (jacci) Bainbridge, BSPharm, PharmD, FCCP, MSCS
|
